ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters

March 23, 2012

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

Course On Human Research Protections Goes Online @ Cancer.Gov.

January 26, 2001

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008